vamicamide has been researched along with oxotremorine in 1 studies
*Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool. [MeSH]
*Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, T; Mukai, T; Nishii, M; Oyasu, H; Ozaki, R; Ozaki, T; Sato, H; Sato, N; Sawada, T; Yamamoto, T | 1 |
1 other study(ies) available for vamicamide and oxotremorine
| Article | Year |
|---|---|
Urinary bladder-selective action of the new antimuscarinic compound vamicamide.
Topics: Animals; Blood Pressure; Dogs; Female; Gastrointestinal Motility; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Muscarinic Antagonists; Muscle, Smooth; Oxotremorine; Parasympatholytics; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Salivation; Stomach; Tissue Distribution; Urinary Bladder; Vas Deferens | 1994 |